Foresite Capital Raises $969 Million to Invest in Early to Late-Stage Companies Transforming Healthcare
Similar Posts
ResBiotic Spins Out Pharmaceutical Subsidiary Alveolus Bio, Raises $4.5M Seed Funding and Launches First Consumer Health Product
The 1st Science-Backed Probiotic for Lung Health is Here Birmingham, Alabama-based biotech startup ResBiotic announced the spin-out of its drug development…
BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform
Strategic funding will support company’s growth and global expansion of continuous multi-parameter monitoring devices and data services for medical…
ShiftMed Raises $200M to Drive Expansion of Leading Digital Health Care Labor Marketplace
With 8x growth in two years, ShiftMed secures capital to accelerate its mission of revolutionizing access to healthcare workers…
Premier Inc. Brands Technology and Services Platform “PINC AI”
Introducing PINC AI – Premier’s new tech and services brand Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today…
